CTNNA1
Catenin alpha-1
Also known as: CAP102, CTNA1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35221
- Gene
- CTNNA1
- Ensembl
- ENSG00000044115
- Chromosome
- 5
- Canonical length
- 906 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Vesicles,Plasma membrane,Cell Junctions,Connecting piece,Mid piece,Principal piece
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the catenin family of proteins that play an important role in cell adhesion process by connecting cadherins located on the plasma membrane to the actin filaments inside the cell. The encoded mechanosensing protein contains three vinculin homology domains and undergoes conformational changes in response to cytoskeletal tension, resulting in the reconfiguration of cadherin-actin filament connections. Certain mutations in this gene cause butterfly-shaped pigment dystrophy. [provided by RefSeq, May 2016]
Canonical amino-acid sequenceUniProt
906 residues, UniProt reviewed canonical sequence.
>P35221|CTNNA1
1 MTAVHAGNIN FKWDPKSLEI RTLAVERLLE PLVTQVTTLV NTNSKGPSNK KRGRSKKAHV
61 LAASVEQATE NFLEKGDKIA KESQFLKEEL VAAVEDVRKQ GDLMKAAAGE FADDPCSSVK
121 RGNMVRAARA LLSAVTRLLI LADMADVYKL LVQLKVVEDG ILKLRNAGNE QDLGIQYKAL
181 KPEVDKLNIM AAKRQQELKD VGHRDQMAAA RGILQKNVPI LYTASQACLQ HPDVAAYKAN
241 RDLIYKQLQQ AVTGISNAAQ ATASDDASQH QGGGGGELAY ALNNFDKQII VDPLSFSEER
301 FRPSLEERLE SIISGAALMA DSSCTRDDRR ERIVAECNAV RQALQDLLSE YMGNAGRKER
361 SDALNSAIDK MTKKTRDLRR QLRKAVMDHV SDSFLETNVP LLVLIEAAKN GNEKEVKEYA
421 QVFREHANKL IEVANLACSI SNNEEGVKLV RMSASQLEAL CPQVINAALA LAAKPQSKLA
481 QENMDLFKEQ WEKQVRVLTD AVDDITSIDD FLAVSENHIL EDVNKCVIAL QEKDVDGLDR
541 TAGAIRGRAA RVIHVVTSEM DNYEPGVYTE KVLEATKLLS NTVMPRFTEQ VEAAVEALSS
601 DPAQPMDENE FIDASRLVYD GIRDIRKAVL MIRTPEELDD SDFETEDFDV RSRTSVQTED
661 DQLIAGQSAR AIMAQLPQEQ KAKIAEQVAS FQEEKSKLDA EVSKWDDSGN DIIVLAKQMC
721 MIMMEMTDFT RGKGPLKNTS DVISAAKKIA EAGSRMDKLG RTIADHCPDS ACKQDLLAYL
781 QRIALYCHQL NICSKVKAEV QNLGGELVVS GVDSAMSLIQ AAKNLMNAVV QTVKASYVAS
841 TKYQKSQGMA SLNLPAVSWK MKAPEKKPLV KREKQDETQT KIKRASQKKH VNPVQALSEF
901 KAMDSILocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTNNA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 202 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 202 nTPM
- heart muscle: 182 nTPM
- blood vessel: 179 nTPM
- colon: 146 nTPM
- adipose tissue: 140 nTPM
- skin: 136 nTPM
Single-cell type
- esophageal apical cells: 1,095 nCPM
- endometrial glandular cells: 930 nCPM
- endometrial luminal cells: 789 nCPM
- alveolar cells type 1: 775 nCPM
- schwann cells: 751 nCPM
- endometrial ciliated cells: 736 nCPM
Immune cell
- non-classical monocyte: 47 nTPM
- intermediate monocyte: 47 nTPM
- classical monocyte: 38 nTPM
- myeloid DC: 32 nTPM
- neutrophil: 21 nTPM
- total PBMC: 18 nTPM
Brain region
- white matter: 210 nTPM
- medulla oblongata: 156 nTPM
- basal ganglia: 155 nTPM
- cerebellum: 143 nTPM
- choroid plexus: 140 nTPM
- thalamus: 136 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CTNNA1.
Disease | AllUniProt
Conditions CTNNA1 is implicated in, by any mechanism.
- Macular dystrophy, patterned, 2 (MDPT2) MIM:608970
Disease | GeneticClinVar
240 pathogenic / likely-pathogenic of 3,561 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 3.66
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apical junction assembly
- axon regeneration
- cell adhesion
- cell migration
- cell-cell adhesion
- cellular response to indole-3-methanol
- epithelial cell-cell adhesion
- establishment or maintenance of cell polarity
- extrinsic apoptotic signaling pathway in absence of ligand
- gap junction assembly
- integrin-mediated signaling pathway
- intracellular protein localization
- male gonad development
- negative regulation of cell motility
- negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
- negative regulation of integrin-mediated signaling pathway
- negative regulation of neuroblast proliferation
- negative regulation of protein localization to nucleus
- neuroblast proliferation
- odontogenesis of dentin-containing tooth
- ovarian follicle development
- positive regulation of extrinsic apoptotic signaling pathway in absence of ligand
- positive regulation of smoothened signaling pathway
- response to estrogen
- smoothened signaling pathway
Molecular functions
- actin filament binding
- beta-catenin binding
- cadherin binding
- gamma-catenin binding
- identical protein binding
- RNA binding
- structural molecule activity
- vinculin binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CTNNA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTNNA1 as an antibody target. Whether an autoantibody or antibody against CTNNA1 could matter depends on whether native CTNNA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTNNA1 is annotated at the cell surface, where native CTNNA1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CTNNA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...